Search tips
Search criteria 


Logo of bmcpmBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Pulmonary Medicine
BMC Pulm Med. 2012; 12: 41.
Published online Aug 8, 2012. doi:  10.1186/1471-2466-12-41
PMCID: PMC3460779

The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis



Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF.


A cross-sectional study was performed, from 2009 to 2011, at University of Campinas – UNICAMP. We analyzed 180 patients for the most frequent mutations in the CFTR gene, presence of the ACE gene D/I polymorphism and clinical characteristics of CF.


There was an association of the D/D genotype with early initiation of clinical manifestations (OR: 1.519, CI: 1.074 to 2.146), bacterium Burkholderia cepacia colonization (OR: 3.309, CI: 1.476 to 6.256) and Bhalla score (BS) (p = 0.015). The association was observed in subgroups of patients which were defined by their CFTR mutation genotype (all patients; subgroup I: no mutation detected; subgroup II: one CFTR allele identified to mutation class I, II or III; subgroup III: both CFTR alleles identified to mutation class I, II and/or III).


An association between the D allele in the ACE gene and the severity of CF was found in our study.

Keywords: Genotype, Phenotype, Variability, Genetic modulation, Angiotensin-converting Enzyme

Articles from BMC Pulmonary Medicine are provided here courtesy of BioMed Central